Literature DB >> 6751633

Spontaneous plaque forming cells in the peripheral blood of patients with systemic lupus erythematosus.

A G Wangel, A Milton, J B Egan.   

Abstract

A reverse haemolytic plaque assay using staphylococcal protein A coupled to sheep red blood cells was set up in Cunningham chambers. Using this method, the numbers of Ficoll-Hypaque isolated peripheral blood lymphocytes (PBL) secreting IgG, IgA or IgM without preceding culture or mitogen stimulation were estimated in patients with systemic lupus erythematosus (SLE) and control subjects. Seven patients with clinically inactive SLE at the time of the study had values similar to those of the control subjects. In contrast, eight patients who had clinically active SLE had markedly increased numbers of PBL secreting IgG, IgA and IgM. Control experiments confirmed that the plaques were due to Ig secretion by lymphoid cells rather than to immune complexes adsorbed onto Fc receptor bearing cells or to passively adsorbed Ig. The results confirm the expected polyclonal B cell activation in patients with SLE and serial measurements showed that clinical relapses occurred only when the numbers of immunoglobulin secreting cells were high. Experiments in three patients with active SLE using native DNA prepared from T2 bacteriophage as the 'developing antigen' suggest that PBL secreting nDNA antibody can also be demonstrated by this method.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6751633      PMCID: PMC1536661     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

Review 1.  A new approach to the study of human B lymphocyte function using an indirect plaque assay and a direct B cell activator.

Authors:  A G Bird; S Britton
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

2.  Deposition of antibodies to a soluble cytoplasmic antigen in the kidneys of patients with systemic lupus erythematosus.

Authors:  P J Maddison; M Reichlin
Journal:  Arthritis Rheum       Date:  1979-08

3.  Impaired immunoglobulin synthesis by peripheral blood lymphocytes in systemic lupus erythematosus.

Authors:  K M Nies; J S Louie
Journal:  Arthritis Rheum       Date:  1978 Jan-Feb

4.  Direct evidence for loss of human suppressor cells during active autoimmune disease.

Authors:  A J Strelkauskas; R T Callery; J McDowell; Y Borel; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

5.  Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus.

Authors:  B Bresnihan; H E Jasin
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

6.  Circulating and pokeweed mitogen-induced immunoglobulin-secreting cells in systemic lupus erythematosus.

Authors:  W W Ginsburg; F D Finkelman; P E Lipsky
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

7.  Suppressor cell defect in SLE: relationship to native DNA binding.

Authors:  R S Krakauer; J D Clough; T Alexander; J Sundeen; D N Sauder
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

8.  Immunoglobulin synthesis by peripheral blood cells in systemic lupus erythematosus.

Authors:  H E Jasin; M Ziff
Journal:  Arthritis Rheum       Date:  1975 May-Jun

9.  Localization of fluorescein-labeled antinucleoside antibodies in glomeruli of patients with active systemic lupus erythematosus nephritis.

Authors:  G A Andres; L Accinni; S M Beiser; C L Christian; G A Cinotti; B F Erlanger; K C Hsu; B C Seegal
Journal:  J Clin Invest       Date:  1970-11       Impact factor: 14.808

10.  A hemolytic plaque assay for activated murine T cells.

Authors:  D Primi; G K Lewis; J W Goodman
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

View more
  8 in total

1.  Histiocytic necrotising lymphadenitis in systemic lupus erythematosus.

Authors:  M D Litwin; B Kirkham; D R Henderson; S C Milazzo
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

2.  Polyclonal B cell activation in paracoccidioidomycosis. Polyclonal activation in paracoccidioidomycosis.

Authors:  D Chequer-Bou-Habib; C Daniel-Ribeiro; D M Banic; A C do Valle; B Galvao-Castro
Journal:  Mycopathologia       Date:  1989-11       Impact factor: 2.574

3.  B lymphocyte activation in systemic lupus erythematosus: spontaneous production of IgG antibodies to DNA and environmental antigens in cultures of blood mononuclear cells.

Authors:  O Dar; M R Salaman; M H Seifert; D A Isenberg
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

4.  Immunoglobulin secretion by peripheral blood and bone marrow B cells in patients with multiple myeloma. Studies by the reverse haemolytic plaque assay.

Authors:  F Dammacco; A Vacca; E Altomare; N Campobasso
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

5.  B cell activating factor (BAFF) and T cells cooperate to breach B cell tolerance in lupus-prone New Zealand Black (NZB) mice.

Authors:  Nan-Hua Chang; Yui-Ho Cheung; Christina Loh; Evelyn Pau; Valerie Roy; Yong-Chun Cai; Joan Wither
Journal:  PLoS One       Date:  2010-07-21       Impact factor: 3.240

6.  B cell activity in systemic lupus erythematosus: depressed in vivo humoral immune response to a primary antigen (haemocyanin) and increased in vitro spontaneous immunoglobulin synthesis.

Authors:  C G Kallenberg; P C Limburg; C Van Slochteren; F J Van der Woude; T H The
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

7.  Characteristics of suppressor factors generated from human mononuclear cells using concanavalin A and C-reactive protein.

Authors:  A G Wangel; S Kontiainen
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

8.  Effects of interferons on human B-cell differentiation in vitro.

Authors:  S Y Kim; H Stoetter; H Heimpel
Journal:  Korean J Intern Med       Date:  1987-07       Impact factor: 2.884

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.